Choose Your Motion with restor3d: Introducing the Latest Personalized Solution in the Kinos Total Ankle System, Kinos Range

Choose Your Motion with restor3d: Introducing the Latest Personalized Solution in the Kinos Total Ankle System, Kinos Range

Jordan Wagner
Vice President of Marketing, restor3d
Phone: (281) 866-4988
Email: Jordan.Wagner@restor3d.com

restor3d, the medical technology leader in 3D printed, personalized orthopedic implants across the entire human body, announced the launch of its latest patient-centric innovation, the addition of the Kinos Range articulating surface to the Kinos Total Ankle System. This new offering of vitamin E, highly crosslinked polyethylene and 3D printed cobalt chrome implants represents a significant advancement in ankle arthroplasty, allowing surgeons t

o assess soft tissue integrity intraoperatively and tailor the resulting articulation to meet each patient’s specific needs. The full system will be on show at the upcoming American Orthopaedic Foot & Ankle Society (AOFAS) and Orthopaedic Summit (OSET) Annual Meetings 2024.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240903303879/en/

Choose Your Motion: Introducing Kinos Range (Photo: Business Wire)

The Kinos Total Ankle System, including the Range Talar and Poly components, introduces the latest in a series of advancements to the Kinos Total Ankle portfolio. This system offers surgeons greater flexibility during procedures, thanks to novel, interchangeable articulations, allowing surgeons to choose between the Kinos Anatomic tri-planar range of motion, or the more restrained Range articulation, based on each patient’s soft tissue or global alignment. Range implants allow for enhanced coronal plane stability and finely tuned biomechanics, while reducing contact stress compared to existing dual condyle implants. Like its Anatomic predecessor, the Kinos Range design demonstrates reduced wear properties in gait simulations due to its improved design over traditional, more constrained total ankle implants.

Brian Garvey, Senior Vice President of Product Development at restor3d, commented, "The continued advancements within the Kinos Total Ankle System are driven by extensive biomechanics research and our commitment to offering surgeons a market leading portfolio for patient-specific care. The intraoperative decision-making capabilities of this system are facilitated by a modular trialing system that enables both articulations to be assessed through the patient's range of motion while dialing in the placement of the definitive implant. Every patient presents with unique factors, and we work to accommodate them all in a personalized manner. This new option in selecting patient specific articulation serves as the foundation for our forthcoming revision and fully personalized ankle implant systems."

Dr. Samuel Adams, MD at Duke University, who completed the first Kinos Range case, stated, "This system offers the stability and flexibility that are critical for successful outcomes across a broad patient demographic. The ability to choose the implant to each patient's unique needs in real-time is a game-changer for orthopedic surgery."

AOFAS attendees are invited to visit restor3d at Booth #807 in the exhibit hall to learn more about these innovative products. restor3d will be hosting a special AOFAS Afterhours event on Thursday, September 12th, at 6:30 PM, featuring presentation from Dr. Kurt Hofmann, MD. This educational session will provide further insights into the Kinos Range addition to the Kinos Total Ankle System and other restor3d offerings.

For those interested in attending the AOFAS Afterhours event, more information and registration details can be found here: Registration Link

OSET attendees are invited to visit restor3d at Booth #709 in the exhibit hall to learn more about these innovative products.

With the launch of the Kinos Range Talar and Poly components, restor3d continues to lead the way in 3D printing and personalized orthopedic solutions, delivering innovative technologies that empower surgeons and improve patient outcomes.

About restor3d, Inc.

restor3d is a world leader in 3D printed patient specific musculoskeletal implants and driven by the belief that every patient deserves personalized care. The company holds proprietary expertise and intellectual property in 3D printing of osseointegrative materials, AI-based planning and design automation tools, and digital health solutions to provide seamless data-backed care to optimize individual patient outcomes. Alongside its customers, restor3d is reimagining the musculoskeletal reconstruction landscape. More information is available at www.restor3d.com.

Forward-Looking Statements

Certain statements made in this release that are not statements of historical or current facts are forward-looking statements which involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to be materially different from historical results or from any future results or projections expressed or implied by such forward-looking statements. In many cases, forward-looking statements can be identified by terms such as “future,” “believes,” “expects,” “may,” “will,” “should,” “potential,” “estimates,” “intends,” “anticipates” or “plans” or the negative of these terms or other comparable terminology. Forward-looking statements are based upon management’s beliefs, assumptions and current expectations but are subject to known and unknown risks and uncertainties including, without limitation, distribution challenges, market trends and demand, product efficacy and safety concerns, product or raw material availability and other supply constraints. Although management believes that the expectations reflected in the forward-looking statements are reasonable, forward-looking statements are not, and should not be relied upon as a guarantee of future performance or results. The forward-looking statements included are made only as the date of this release. The company assumes no obligation to update any information or forward-looking statement contained herein, save for any information required to be disclosed by law.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240903303879/en/